Description
Afatinib dimaleate is a medication primarily used in the treatment of metastatic non-small cell lung cancer (NSCLC) that harbors specific genetic mutations known as EGFR (epidermal growth factor receptor) mutations. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of certain proteins involved in cancer cell growth and spread. Afatinib is specifically indicated for patients with NSCLC whose tumors have EGFR mutations. It is typically taken orally in tablet form.
Savannah (verified owner) –
The quality of these product is truly impressive. They work perfectly for my needs, and I’m very satisfied.
Frances (verified owner) –
The packaging for my product was very secure. Everything arrived intact and in perfect condition.
Willard (verified owner) –
The packaging for my product was secure and well-done. Everything arrived in perfect condition.
Santo (verified owner) –
The packaging for my product was excellent. Everything was securely wrapped and arrived without any issues.